BridgeMD
New treatment option for Cancer
Official title Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
ClinicalTrials.gov ID: NCT07061652
What this study is testing
- What it's testing
- This study investigates the feasibility, acceptability, and preliminary efficacy of enCompass Humana, a social support intervention for caregivers of patients with cancer and diabetes. The enCompass program aims to improve support for these caregivers through a randomized feasibility study of a pilot-tested coaching and navigation program.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99. Healthy volunteers may be eligible.
You may be able to join if
- for Caregivers
- English-speaking.
- Ability to provide written or verbal informed consent to participate in the study;
- Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee;
- Be at least 18 years of age at the time of consent; and
You likely can't join if
- Exclusion Criteria for Caregivers
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol;
- Participation in the intervention development phase of this intervention Exclusion Criteria for patients
- Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
See the full eligibility criteria
- for Caregivers
- English-speaking.
- Ability to provide written or verbal informed consent to participate in the study;
- Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee;
- Be at least 18 years of age at the time of consent; and
- Identify as an informal (unpaid) caregiver for an adult with a stage II-IV cancer AND diabetes. for patients
- English-speaking
- Ability to provide informed consent.
- Be at least 18 years of age at the time of consent; and
- Their identified caregiver is enrolled in the study
- Diagnoses: (must have cancer and diabetes)
- Have a cancer diagnosis for which they are being actively treated at one of the study sites
- Have a cancer diagnosis, stage II-IV solid tumor or any hematologic malignancy
- Receiving active cancer treatment s, not including hormonal therapy
- Concurrent history of diabetes with need for ongoing management
- Exclusion Criteria for Caregivers
- Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol;
- Participation in the intervention development phase of this intervention Exclusion Criteria for patients
- Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
- Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol;
- Their caregiver does not enroll in the study or withdraws consent
The study team makes the final eligibility decision.
Where it's taking place
- Tampa, Florida, United States
- Chapel Hill, North Carolina, United States
- Burlington, Vermont, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tampa, Florida, United States; Chapel Hill, North Carolina, United States; Burlington, Vermont, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.